exv10w1






Exhibit 10.1




AMENDMENT AGREEMENT



THIS AMENDMENT AGREEMENT (this “Agreement”) is dated as of June 29, 2011 and made by and between:





	(1)	 	private persons, corporations and private equity funds listed in Appendix A (“Sellers”); and
	 
	(2)	 	American Superconductor Corporation, a corporation incorporated and existing under the laws
of Delaware, United States, having its principal place of business at 64 Jackson Road Devens,
MA 01434, United States (“Purchaser”).




(Each also referred to as “Party” or together as “Parties”)




WHEREAS





	(A)	 	On March 12, 2011, the Parties entered into a share purchase agreement (the “SPA”) regarding
the sale and purchase of the shares in The Switch Engineering Oy.
	 
	(B)	 	On April 5, 2011, Purchaser issued a press release stating that Sinovel Wind Group Co., Ltd.,
Purchaser’s key customer, had refused to accept contracted shipments of 1.5 megawatt (MW) and
3 MW wind turbine core electrical components and spare parts that Purchaser was prepared to
deliver.
	 
	(C)	 	On May 31, 2011, Purchaser issued a press release stating, among other matters, that
Purchaser is currently reviewing options to secure additional financing to enable the company
to complete its acquisition of The Switch Engineering Oy. Purchaser has informed Sellers that
it will need additional time to complete the required financing and has proposed to Sellers
that the SPA be amended and the Closing Date (as defined in the SPA) deferred.
	 
	(D)	 	The Parties acknowledge that pursuant to Section 12.10 of the SPA, any amendment to the SPA
shall be in writing and shall have no effect before signed by the duly authorized
representatives of each Party.
	 
	(E)	 	The Parties hereby wish to agree to amend the SPA in accordance with the terms and conditions
of this Agreement.
	 
	(F)	 	Simultaneously with this Agreement, the Parties have entered into an amendment agreement in
respect of the Stockholders Agreement attached hereto as Exhibit 1.
	 
	(G)	 	Upon the execution of this Agreement, Purchaser shall pay to Sellers the Advance Payment (as
defined below).
	 
	(H)	 	All capitalized terms not defined in this Agreement shall have the same meaning as ascribed
to them in the SPA.





 









 





NOW, THEREFORE, IT IS AGREED:




1. AMENDMENTS TO THE SPA




1.1 Section 1 (Definitions)



The following definitions shall be deemed to be included in Section 1 of the SPA:




	 	 	 

	“Advance Payment”

	 	means an advance payment of EUR fourteen million two hundred fifty
thousand (14,250,000) by Purchaser to Sellers upon the execution of the Amendment
Agreement, being a part of the Purchase Price and reducing the cash portion of the
Payment to be made at Closing, and constituting a termination fee to Sellers in the
event this Agreement is terminated pursuant to Section 6.6 (i) by Sellers or Purchaser
upon the occurrence of the Failed Financing Event or (ii) by Purchaser upon the
occurrence of a Material Adverse Effect.
	 
	 	 
	“Amended and Restated
Stockholders’ Agreement”

	 	means the Stockholders’ Agreement dated March 12, 2011 and as
amended as of the date hereof.
	 
	 	 
	“Amendment Agreement”

	 	means the amendment agreement among the Parties executed on June 29,
2011 amending certain terms of this Agreement.
	 
	 	 
	“Purchaser Financing”

	 	means the issuance of convertible notes, stock or other instruments or
obtaining of other forms of financing, as determined by Purchaser, resulting in a
minimum of USD 100 million in net cash available to Purchaser post-financing and
post-Closing for working capital purposes.






1.2 Section 4.1 (Purchase Price)



The first paragraph of Section 4.1 of the SPA is hereby amended to read as follows:





	 	 	“The Purchase Price for the Shares owned and held by Sellers shall be the aggregate of (i)
EUR one hundred and ninety million (190,000,000) and (ii) in the event Closing occurs after
September 1, 2011, interest at an annual rate of 4.00% on EUR one hundred eighteen million
seven hundred fifty thousand (118,750,000), representing the cash portion of the Purchase
Price less the Advance Payment, accruing from September 1, 2011 until the Closing Date
(inclusive) (the “Purchase Price”).”





1.3 Section 4.2 (Payment of Purchase Price)



The first paragraph of Section 4.2 of the SPA is hereby amended to read as follows:





	 	 	“Upon the execution of the Amendment Agreement, Purchaser shall pay an amount equal to the
Advance Payment in cash to Sellers’ joint bank account at Skandinaviska




-2-









 






	 	 	Enskilda Banken AB (publ) Helsinki Branch, IBAN number FI1233010001103217 and BIC/SWIFT code
ESSEFIHX.
	 
	 	 	At Closing, Purchaser shall pay






	 	 	 	(i) EUR one hundred and seventy-one million (171,000,000), i.e. ninety per cent (90
%) of the Purchase Price in cash to Sellers’ joint bank account at Skandinaviska
Enskilda Banken AB (publ) Helsinki Branch, IBAN number FI1233010001103217 and
BIC/SWIFT code ESSEFIHX, and in unregistered shares of Purchaser Common Stock
delivered in accordance with this Section 4.2 (jointly, the “Payment”). The amount
equal to the Advance Payment paid by Purchaser to Sellers upon the execution of the
Amendment Agreement shall be applied towards to cash portion of the Purchase Price
payable at Closing.
	 
	 	 	 	(ii) EUR nineteen million (19,000,000), i.e. ten per cent (10%) of the Purchase
Price, in cash and in unregistered shares of Purchaser Common Stock at Closing to
escrow (the “Escrow Payment”) delivered in accordance with this Section 4.2 and
Section 4.4 below.”




Section 4.2(a) of the SPA is hereby amended to read as follows:





	 	 	“(a) Sellers other than the Directors and the Minor Sellers will receive approximately 73%
of their portion of the Purchase Price in cash and approximately 27% in unregistered shares
of Purchaser Common Stock, and the Directors will receive approximately 40% of their
portion of the Purchase Price in cash and approximately 60% in unregistered shares of
Purchaser Common Stock (subject to certain restrictions pursuant to the Stockholders’
Agreement) as set forth in Appendix 4.2. The number of shares of Purchaser Common Stock to
be issued and delivered as part of the Payment to such Sellers at Closing will be calculated
on the basis of (i) the average closing price of shares of Purchaser Common Stock in the
Nasdaq Global Market during the twenty (20) trading-day period ending on the second
(2nd) Business Day in the United States preceding the Closing Date and (ii) the
USD/EUR exchange rate published in Financial Times (European print edition) on the second
Business Day preceding the Closing Date. The Parties shall jointly prepare a calculation of
the cash and the number of shares of Purchaser Common Stock to be paid to each such Seller
on the last Business Day preceding the Closing Date.”




Appendix 4.2 of the SPA is amended as set forth in Exhibit 2.



Section 4.2(b) of the SPA is hereby deleted in its entirety and the numbering of Section 4.2(c) is
therefore changed to Section 4.2(b). All references in the SPA to Sections 4.2(b) and 4.2(c) shall
hereby refer to Sections 4.2(a) and 4.2(b), respectively.



The last paragraph of Section 4.2 of the SPA is hereby amended to read as follows:





	 	 	“In the event that the total number of shares of Purchaser Common Stock issuable pursuant to
this Section 4.2 would exceed 19.9% of the total number of shares of Purchaser Common Stock
outstanding prior to such issuance, no shares of Purchaser Common Stock exceeding such
amount will be issued and the deficiency in such portion of the Purchase Price (the
“Shortfall Amount”) will be paid by Purchaser as




-3-









 






	 	 	follows: (i) to the Minor Sellers, in cash; (ii) to Sellers other than the Minor Sellers, by
delivering to such Sellers at Closing an unsecured promissory note with nominal amount equal
to the Shortfall Amount and accruing interest from the Closing Date until the repayment of
such note on the first (1st) Business Day after the first anniversary of the
Closing Date at the rates specified in the form of such promissory note, which is attached
to the Amendment Agreement as Exhibit 3.”





1.4 Section 4.4 (Escrow Arrangement)



Each reference in Section 4.4 of the SPA to the Release Date being twelve (12) months after the
Closing Date shall be deleted and replaced by a reference to the Release Date being June 10, 2012.




1.5 Section 6.1 (Closing)



The first paragraph of Section 6.1 of the SPA is hereby amended to read as follows:





	 	 	“The Closing shall take place on the tenth (10th) Business Day from the date on
which Purchaser has informed in writing Sellers that the Purchaser Financing has been
completed and proceeds paid to Purchaser, provided that all the other conditions precedent
for Closing as set forth in Section 6.3 (as amended under the Amendment Agreement) (other
than deliveries agreed to occur at Closing) have been fulfilled or duly waived (the “Closing
Date”).”





1.6 Section 6.2 (Sellers’ Conditions Precedent)



Section 6.2 of the SPA is hereby amended to read as follows:





	 	 	“The obligation of Sellers to consummate the transactions to be performed by them in
connection with Closing is subject to satisfaction of the following conditions:






	 	6.2.1	 	Purchaser shall have prepared and completed the conversion in EDGAR form for
filing with the SEC of the Shelf Registration Statement that complies in all material
respects with the applicable requirements of the Securities Act, Purchaser’s counsel
shall have prepared the Blanket Opinion in draft form and Purchaser shall have provided
a copy of such Shelf Registration Statement in EDGAR form and draft Blanket Opinion to
Sellers not later than one (1) Business Day prior to the Closing Date (the Parties
acknowledge that this condition shall be deemed to be satisfied even if such documents
omit information regarding the number of shares to be registered and other information
derived therefrom or omit information to be obtained from selling securityholder
questionnaires); capitalized terms used and not otherwise defined herein shall have the
meanings ascribed to such terms in the Amended and Restated Stockholders’ Agreement;
and
	 
	 	6.2.2	 	Due fulfilment by Purchaser of its respective deliveries at Closing as set
forth in Section 6.4.






	 	 	Sellers may, at their sole discretion, waive any and all of the conditions specified in this
Section 6.2 at or prior to Closing.”




-4-









 












	1.7	 	Section 6.3 (Purchaser’s Conditions Precedent)




Section 6.3 of the SPA is hereby amended to read as follows:





	 	 	“The obligation of Purchaser to consummate the transactions to be performed by it in
connection with Closing is subject to satisfaction of the following conditions:






	 	6.3.1	 	All of the agreements and covenants of Sellers in Section 2.1 (Ownership),
Section 5 (Transfer of Title and Assignment), Section 6.6 (Reasonable Efforts to
Close), Section 11.4 (Ordinary Course of Business), Section 11.5 (Obligation to
Inform), Section 11.6 (Access to Information) and Section 11.7 (U.S. GAAP Financial
Statements) to be performed prior to Closing pursuant to this Agreement shall have been
duly performed in all material respects. In case of a material breach of the above
listed agreements and covenants, Sellers shall have the right to fulfil this condition
if Sellers remedy and rectify the breach within ten (10) Business Days after the breach
or, in case the breach cannot be or is not rectified, but the breach can be quantified
in money and thus rectified by compensating the Purchaser, indemnify Purchaser at
Closing for such breach on a euro-for-euro basis by a reduction in the cash portion of
the Purchase Price or a cash payment to Purchaser With respect to Section 11.7 (U.S.
GAAP Financial Statements), it is understood and accepted that Sellers shall always
have not less than twenty (20) days after the end of the relevant calendar quarter to
deliver the U.S. GAAP Financial Statements;
	 
	 	6.3.2	 	No Material Adverse Effect shall have occurred between Signing and Closing;
and
	 
	 	6.3.4	 	Due fulfilment by Sellers of their respective deliveries at Closing as set
forth in Section 6.4 below.






	 	 	Purchaser may, at its sole discretion, waive any and all of the conditions specified in this
Section 6.3 at or prior to Closing.”





1.8 Section 6.6 (Reasonable Efforts to Close)



The second paragraph of Section 6.6 of the SPA is hereby amended to read as follows:





	 	 	“If Closing has not taken place on or before September 30, 2011 or ten (10) Business Days
thereafter in case of a breach and/or failure to remedy by Sellers under Section 6.3.1 (the
“Long-Stop Date”), the Parties shall have the right (subject to the last paragraph of this
Section 6.6) to terminate this Agreement as follows:






	 	(i)	 	Sellers shall have the right to terminate this Agreement without incurring any
liabilities towards Purchaser (A) if the conditions precedent set forth in Section 6.2
have not been fulfilled or waived as a result of Purchaser’s failure to satisfy such
conditions precedent and such failure constitutes a material breach of Purchaser’s
undertakings agreed in the SPA or (B) if Purchaser has not informed Sellers that the
Purchaser Financing has been completed and proceeds paid to Purchaser (the “Failed
Financing Event”), provided that Sellers have complied with their obligations under
Section 11.7. If Sellers terminate this Agreement pursuant to this paragraph (i),
Purchaser will forfeit the Advance




-5-









 






	 	 	 	Payment paid upon the execution of this Agreement and the Parties shall have no right
to make any further claims against each other.
	 
	 	(ii)	 	Purchaser shall have the right to terminate this Agreement without incurring any
liabilities towards Sellers or the Group Companies (A) if the conditions precedent set
forth in Section 6.3 have not, subject to Sellers’ right to remedy and rectify under
Section 6.3.1, been fulfilled or waived (and in the case of Section 6.3.3 if such
failure also constitutes a material breach of Sellers’ undertakings agreed in the SPA)
or (B) upon a Failed Financing Event. If Purchaser terminates this Agreement because the
condition precedent set forth in Section 6.3.2 has not been fulfilled or upon a Failed
Financing Event, Purchaser will forfeit the Advance Payment paid upon the execution of
this Agreement. In case of termination by Purchaser under sub-section (A) above, Sellers
shall have no right to make any further claims against Purchaser, including for
reimbursement of expenses incurred in connection with the transaction, and in case of
termination under sub-section (B) above, the Parties shall have no right to make any
further claims against each other, including for reimbursement of expenses incurred in
connection with the transaction. If Purchaser terminates this Agreement because the
conditions precedent set forth in Section 6.3 (excluding Section 6.3.2) have not been
fulfilled, subject to Seller’s right to remedy and rectify under Section 6.3.1, Sellers
shall return the Advance Payment within seven (7) Business Days after having received
Purchaser’s written termination notice. For the sake of clarity the Purchaser is not
entitled to terminate this Agreement under sub-section (A) above in case Sellers’ breach
of the agreements and covenants under Section 6.3.1 is not material or is rectified,
remedied or compensated by Sellers in accordance with Section 6.3.1. For the avoidance
of doubt, it is expressly stated and acknowledged by the Parties that nothing stated in
Section 6.6 shall constitute an obligation for Sellers to indemnify Purchaser in case of
the Failed Financing Event.






	 	 	In the event Closing has not taken place on or before the Long-Stop Date as a result of
pending Purchaser Financing, the Long-Stop Date shall be extended upon Purchaser’s written
notice to Sellers by no more than two one-month periods in time, provided that Purchaser
informs Sellers that preparations to obtain the Purchaser Financing are pending and that
Purchaser still expects to receive the Purchaser Financing.”





1.9 Section 7 (Representations and Warranties of Sellers)



The fourth paragraph of Section 7 of the SPA is hereby amended to read as follows:





	 	 	“Sellers may, at the latest two (2) Business Days prior to the date of the Amendment
Agreement, deliver to Purchaser updates to the Disclosure Letter in the form of an updated
disclosure letter (“Updated Disclosure Letter”) in order to disclose or take into account
facts, matters or circumstances which have arisen or occurred after the date of this
Agreement and which, if existing or occurring as of the date hereof, would have been
required to be set forth in this Agreement or in the Disclosure Letter as an exception of
the Warranties. The Updated Disclosure Letter shall have the same effect as the Disclosure
Letter pursuant to this Agreement.”




-6-









 











1.10 Section 9.1 (Indemnity of Purchaser)



The second paragraph of Section 9.1 of the SPA is hereby amended to read as follows:





	 	 	“For the sake of clarity it is stated here and agreed hereby that any amount payable by
Sellers to Purchaser under this Section 9 shall be paid primarily and first from the Escrow
Account pursuant to the terms of the Escrow Agreement. It is expressly agreed that as of
June 10, 2012 the Warrantors shall solely assume liability for the Warranties granted and
for possible Claims presented by Purchaser after such date under this Agreement and the
other Sellers shall thus be released from liability under this Agreement as per such date
other than in respect of Claims made prior to such date.”





1.11 Section 9.2.2 (Time Limitations)



Section 9.2.2 of the SPA is hereby amended to read as follows:





	 	 	“No Claim shall be brought against Sellers and Sellers shall not be liable in respect of any
Claim unless notice in writing of any such Claim (accompanied by all relevant particulars
thereof specifying the nature of the breach, the estimated amount claimed in respect thereof
and all such other information as is available to Purchaser as is reasonably necessary to
enable Sellers to assess the merits of the Claim, to act to preserve evidence and to make
such provision as Sellers may consider necessary) has been given to Sellers within sixty
(60) days from the date Purchaser became aware of the circumstances giving rise to such
Claim and in any event not later than June 10, 2012, provided that Purchaser shall not be
precluded from making a Claim after such 60-days period prior to June 10, 2012 in the event
and to the extent that Purchaser’s failure to notify in such time has not aggravated to any
extent the Loss that is subject to the Claim or made it from an objective perspective
commercially or technically unreasonable to rectify the breach of the Claim.
	 
	 	 	However, (i) Claims under Section 7.10 (Intellectual Property Rights), Section 7.12
(Environmental matters) and Section 7.20(b) (Anti-Bribery Laws) shall be presented no later
than June 10, 2013, (ii) Claims under Section 7.9 (Taxes) shall be presented no later than
six (6) months from the date upon which the applicable statutory limitation periods expire,
and (iii) Claims under Section 7.1 (Ownership of Shares and Authority of Sellers) and
Section 7.2 (Existence) and due to fraud or wilful misconduct by Sellers shall be presented
no later than June 10, 2016.”





1.12 Section 9.3 (Joint and Several Liability)



The second paragraph of Section 9.3 of the SPA is hereby amended to read as follows:





	 	 	“To the extent Sellers may be held liable for any Claims presented after June 10, 2012
and/or to the extent Sellers may be held liable for Claims exceeding the Escrow Payment, the
Warrantors shall as of June 10, 2012 onwards be liable for such possible Claims. The
Warrantors’ liability as of such date for any breaches of Warranties shall be several and
not joint and calculated in proportion to their holding of Shares.”






	1.13	 	Section 11.7 (U.S. GAAP Financial Statements)




Section 11.7 of the SPA is hereby amended to read as follows:







-7-









 









	 	 	“Sellers undertake to procure that the Company (i) prepares at its cost the U.S. GAAP
Financial Statements (as defined below) as soon as reasonably possible after the date of the
Amendment Agreement, (ii) consults with Purchaser and its accountants in preparing such US
GAAP Financial Statements and, to the extent reasonable, take into consideration any
comments Purchaser and its accountants may have, and (iii) delivers such U.S. GAAP Financial
Statements to Purchaser no later than twenty (20) days after the end of the relevant
calendar quarter. For the purposes of this Section 11.7 the “U.S. GAAP Financial Statements”
shall mean, the financial statements of Company (prepared in the same manner as the previous
financial statements prepared and provided by the Company and accepted by Purchaser)
required to be included in, or necessary for the preparation of the pro forma financial
information required to be included in, the Shelf Registration Statement (as defined in the
Stockholders Agreement) or Purchaser’s current report on its Form 8-K reporting the
consummation of the transactions contemplated hereby.”





1.14 Section 11.8 (Ordinary Course of Business of Purchaser)



The provision (C) in paragraph (iv) of Section 11.8 of the SPA is hereby amended to read as
follows:





	 	(C) issuing shares in capital stock, convertible notes or other equity instruments of
Purchaser in connection with the Purchaser Financing or in connection with any merger,
acquisition or purchase of all or a substantial portion of the assets of any Person other
than the Company.





1.15 Appendix 4.2 of the SPA



With effect from the date of this Agreement, Appendix 4.2 (Payment and Allocation of
Purchase Price) of the SPA shall be replaced in its entirety with a new appendix which has been
attached to this Agreement as Exhibit 4.




2. OTHER TERMS



All other terms of the SPA not amended by this Agreement shall continue to remain in full force and
effect as set forth therein and shall apply to the matters agreed in this Agreement




[SIGNATURES TO FOLLOW]






-8-









 







IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the
date first above written.




PURCHASER:




AMERICAN SUPERCONDUCTOR CORPORATION




	 	 	 	 	 

	/s/ Daniel P. McGahn 

Daniel P. McGahn

	 	 	 	 
	President and Chief Executive Officer	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	SELLERS:
	 	 	 	 
	 
	 	 	 	 
	POWER FUND I KY

	 	POWER FUND II KY	 	 
	 
	 	 	 	 
	/s/ Veijo Karppinen 

Veijo Karppinen

	 	/s/ Veijo Karppinen 

Veijo Karppinen
	 	 
	 
	 	 	 	 
	VACON PLC GMBH

	 	SEMIKRON INTERNATIONAL	 	 
	 
	 	 	 	 
	/s/ Vesa Laisi 

Vesa Laisi

	 	/s/ Veijo Karppinen (by proxy) 

Dirk Heidenreich
	 	 
	 
	 	 	 	 
	START FUND I KY
	 	 	 	 
	 
	 	 	 	 
	/s/ illegible (by proxy) 

Henri Grundstén

	 	/s/ Dag Sandås (by proxy) 

Jukka-Pekka Mäkinen
	 	 






-9-









 






	 	 	 	 	 

	/s/ Dag Sandås 

Dag Sandås

	 	/s/ Dag Sandås (by proxy) 

Pertti Kurttila
	 	 
	 
	 	 	 	 
	/s/ Dag Sandås (by proxy) 

Reijo Takala

	 	/s/ Dag Sandås (by proxy) 

Jari Kemppi
	 	 
	 
	 	 	 	 
	/s/ Dag Sandås (by proxy) 

Anders Troedson

	 	/s/ Dag Sandås (by proxy) 

Jukka Rantanen
	 	 
	 
	 	 	 	 
	/s/ Veijo Karppinen (by proxy) 

Veijo Karppinen

	 	 	 	 
	on behalf of Sellers listed in Appendix A hereto	 	 







-10-









 








APPENDIX A




SELLERS



	 

	Power Fund I Ky

	Semikron International GmbH

	Vacon Oyj

	Start Fund I Ky (Tesi)

	Jukka-Pekka Mäkinen

	Dag Sandås

	Pasi Törmänen

	Veli Pesonen

	Reijo Takala

	Jorma Laukkanen

	Dejan Schreiber

	Jussi Huppunen

	Jarmo Alamäki

	Tom O’Reilly

	Juha Pyrhönen

	Olli Pyrhönen

	Harri Ollila

	Ari Korhonen

	Panu Kurronen

	Kim Söderman

	Marko Kristola

	Arto Mäkynen

	Pekka Yli-Mutka

	Mika Jantunen

	Sari Vallinmäki

	Alpo Vallinmäki

	Hanna Niemelä

	Pertti Silventoinen

	Ari Suutarinen

	The Switch Engineering Oy

	Tuula Turku

	Marina Ranta

	Jixiang Hao

	Sergey Groshev

	Anssi Lipsanen

	Mikko Hämäläinen

	Jussi Paakkunainen

	Roman Russell

	Marko Tuuha

	Jussi Puranen

	Karl Bond Jr

	VNT Management Oy

	Marianne Munkki

	Ulla-Riitta Nummi







-11-









 






	 

	Arita Rajala

	Antti Suikki

	Janne Partinen

	Kaj Rönnlund

	Pasi Koskela

	Sami Wainio

	Pertti Kurttila

	Zhao Ti

	Ikonen Mika

	Baoquan Liu

	Mäntylä Mika

	Pirkola Sami

	Raunio Mari-Lotta

	Alho Timo

	Toura Matias

	Koskiniemi Kari

	Lehtonen Mari

	Nykänen Päivi

	Troedson Anders

	Lipsanen Esa

	Vilhu Mika

	Heinonen Seppo

	Autio Pekka

	Ala Milla

	Hertsbacka Henna

	Hewitt Simon

	Hiipakka Laila

	Hyvärinen Jennimaria

	Isotalo Esko

	Koskela Mika

	Lewing Raimo

	Malm Markus

	Miekka Jan

	Pesu Pia

	Pohtola Janne

	Reinilä Juha

	Tattari Johanna

	Tattari Marika

	Vepsäläinen Jari

	Åberg Rosmari

	Kangasmäki Timo

	Jaaksi Lilja

	Ahonen Mikko

	Backlund Marcus

	Kaakinen Otto

	Koiranen Johanna

	Salmela Marko

	Westerberg Anders







-12-









 






	 

	Wei Li

	ZhaoLi Song

	Power Fund II

	Isokangas Juha-Matti

	Huovila Jukka

	Xu Junjie

	Kannanniemi Vesa

	Tuominen Hanna

	Pääkkönen Mikko

	Ahvo Risto

	Black Paul

	Koskinen Mona

	Kankaala Kari

	Rantanen Jukka

	Desai Piyush

	Alatalo Mika

	Järvelä Jyri

	Isuls Maria

	Alho Matti

	Kemppi Jari

	Reinikka Miika

	Pohjola Mikko

	Kettman-Kervinen Lisa

	Sabine Doms

	Pekka Hermunen

	WeiJie Qiu

	Xue Bai

	Ville Sihvo

	Mathias Martin

	Pasi Kalervo

	Jukka Viitasalo

	Juha Mansikka-Aho

	Ari Sippola

	Xiting Zhang

	Carlo Cecchi







-13-









 





Exhibit 1




AMENDED AND RESTATED

STOCKHOLDERS AGREEMENT




          AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), dated June 29, 2011,
by and among American Superconductor Corporation, a Delaware corporation (the “Company”),
and the Persons listed on Schedule I attached hereto (each, a “Stockholder” and
collectively, the “Stockholders”).




W I T N E S S E T H :




          WHEREAS, the Company and the Stockholders are parties to that certain Stockholders Agreement,
dated March 12, 2011, among the Company and the Stockholders (the “Prior Agreement”), and
the Company and the Stockholders desire to amend and restate the Prior Agreement in its entirety;




          WHEREAS, upon the consummation of the transactions contemplated by that certain Purchase
Agreement, each Director and Other Stockholder will become the record and beneficial owner of that
number of shares of Common Stock of the Company, par value $0.01 per share (“Common
Stock”), as calculated in accordance with Section 4.2(a) of the Purchase Agreement and to be
reflected on Schedule I attached hereto in accordance with Section 5.4(b);




          WHEREAS, the Company and the Directors each desire to enter into this Agreement to limit the
sale, assignment, transfer, encumbrance or other disposition of any Securities which may be held by
the Directors from time to time and for the Directors to make certain additional representations
and warranties to the Company in connection with the acquisition of Common Stock by the Directors
under the Purchase Agreement as set forth in further detail below; and




          WHEREAS, the Company and the Other Stockholders each desire to enter into this Agreement for
the Other Stockholders to make certain additional representations and warranties to the Company in
connection with the acquisition of Common Stock by the Other Stockholders and to provide for the
registration of the shares of Common Stock to be acquired by the Other Stockholders for the resale
by such Other Stockholders in compliance with the Securities Act, in each case under the Purchase
Agreement as set forth in further detail below.




          NOW, THEREFORE, in consideration of the mutual covenants set forth herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound, hereby agree that the Prior Agreement shall be amended and
restated in its entirety to read as follows:







 









 








ARTICLE I




CERTAIN DEFINITIONS



          Section 1.1 Certain Definitions. For purposes of this Agreement, the following terms
shall have the following meanings:




          “Affiliate” shall mean, with respect to any Person, any other Person directly or
indirectly controlling, controlled by, or under common control with, such Person; provided
that, for the purposes of this definition, “control” (including, with correlative meanings, the
terms “controlled by” and “under common control with”), as used with respect to any Person, shall
mean the possession, directly or indirectly, of the power to direct or cause the direction of the
management and policies of such Person, whether through the ownership of voting securities, by
contract or otherwise.




          “Agreement” shall have the meaning set forth in the preamble to this Agreement.




          “Blanket Opinion” shall have the meaning set forth in Section 5.1(a).




          “Board” shall mean the Board of Directors of the Company.




          “Business Day” shall mean any day, other than a Saturday, Sunday or other day on which
banks located in New York City, New York or Finland are authorized or required by Law to close.




          “Closing” shall mean the consummation of the transactions contemplated in the Purchase
Agreement as described in Section 6 thereof.




          “Closing Date” shall have the meaning set forth in Section 6.1 of the Purchase
Agreement.




          “Common Stock” shall have the meaning set forth in the second recital to this
Agreement. For the avoidance of doubt, all references in this Agreement to the Common Stock
include the Common Stock deposited by the Stockholders with the Escrow Agent pursuant to the Escrow
Agreement.




          “Company” shall have the meaning set forth in the preamble to this Agreement.




          “Directors” shall mean those Stockholders who are designated as Directors on Schedule
I hereto and shall include such other Persons who, after the date hereof, become a Stockholder
hereunder and are designated as a Director upon executing this Agreement or having acceded to this
Agreement and the Purchase Agreement in accordance with Section 2.1 of the Purchase Agreement.







2









 








          “Disclosure Package” means, with respect to any offering of Registrable Securities,
(i) the prospectus included in the Shelf Registration Statement, (ii) each Free Writing Prospectus
and (iii) all other information, in each case, that is deemed, under Rule 159 promulgated under the
Securities Act, to have been conveyed to purchasers of Registrable Securities at the time of sale
of such Registrable Securities (including a contract of sale).




          “Escrow Agent” shall have the meaning ascribed thereto in the Escrow Agreement.




          “Escrow Agreement” shall mean that certain Escrow Agreement set forth in Appendix 1.24
to the Purchase Agreement to be executed at the Closing.




          “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the SEC promulgated thereunder.




          “Free Writing Prospectus” means any “free writing prospectus” as defined in Rule 405
promulgated under the Securities Act.




          “Governmental Entity” shall mean any instrumentality, subdivision, court,
administrative agency, commission, official or other authority of the United States or any other
country or any state, province, prefect, municipality, locality or other government or political
subdivision thereof, or any quasi-governmental or private body exercising any regulatory, taxing,
importing or other governmental or quasi-governmental authority.




          “Law” shall mean any statute, law, common law, order, ordinance, rule or regulation of
any Governmental Entity.




          “Non-Accredited US Stockholders” shall mean those Stockholders with two asterisks (**)
set forth next to each of their names on Schedule I attached hereto.




          “Non-US Stockholders” shall mean those Stockholders who are not US Stockholders.




          “Other Stockholders” shall mean those Stockholders who are designated as Other
Stockholders on Schedule I hereto and shall include such other Persons who, after the date hereof,
become a Stockholder hereunder and are designated as an Other Stockholder upon executing this
Agreement or having acceded to this Agreement and the Purchase Agreement in accordance with Section
2.1 of the Purchase Agreement.




          “Other Stockholder Free Writing Prospectus” means each Free Writing Prospectus
prepared by or on behalf of the relevant selling Other Stockholder or used or referred to by such
Other Stockholder in connection with the offering of Registrable Securities.




          “Permitted Transfer” shall have the meaning set forth in Section 2.2(a) of this
Agreement.







3









 








          “Permitted Transferee” shall have the meaning set forth in Section 2.2(a) of this
Agreement.




          “Person” shall mean and include an individual, a partnership, a joint venture, a
corporation, a limited liability company, a limited liability partnership, a trust, an incorporated
organization or any other entity or organization, including a Governmental Entity.




          “Purchase Agreement” shall mean that certain Share Purchase Agreement, dated as of
March 12, 2011 and as amended on June 29, 2011, by and among the Company and the Persons listed on
Appendix A thereto, on behalf of themselves and the Persons listed on Appendix B thereto.




          “Registrable Securities” shall mean the shares of Common Stock issued by the Company
to the Other Stockholders pursuant to the Purchase Agreement and any shares of capital stock of any
Person issued or issuable with respect of such shares of Common Stock as a result of any stock
split, stock dividend or similar event that would be automatically covered by the Shelf
Registration Statement pursuant to Rule 416 under the Securities Act.




          “Regulation S” shall have the meaning set forth in Section 3.3(b) of this Agreement.




          “SEC” shall mean, at any time, the United States Securities and Exchange Commission or
any other federal agency at such time administering the Securities Act.




          “SEC Reports” shall have the meaning set forth in Section 4.1(a) of this Agreement.




          “Securities” shall mean all shares of Common Stock of the Company, all securities,
directly or indirectly, convertible into or exchangeable for shares of Common Stock of the Company
and all options, warrants, and other rights to purchase or otherwise, directly or indirectly,
acquire from the Company shares of Common Stock, or securities convertible into or exchangeable for
shares of Common Stock, whether at the time of issuance or upon the passage of time or the
occurrence of some future event.




          “Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and
regulations of the SEC promulgated thereunder.




          “Sellers’ Representatives” shall have the meaning set forth in Section 2.3(b) of this
Agreement.




          “Selling Securityholder Questionnaire” shall have the meaning set forth in Section
5.1(a).




          “Shelf Registration Period” shall have the meaning set forth in Section 5.1(b).







4









 








          “Shelf Registration Statement” shall mean a registration statement on Form S-1 (or, if
available to the Company, Form S-3) under the Securities Act, as amended and/or supplemented by all
amendments, including post-effective amendments, and supplements, including prospectus supplements,
thereto, covering the registration of the Registrable Securities under the Securities Act for
resale by the Other Stockholders.




          “Stockholder” shall have the meaning set forth in the preamble to this Agreement,
subject to Section 2.2 hereof. The term “Stockholder” shall, however, include and be limited to
those Persons who are, at the Closing Date, included in the definition of Sellers in accordance
with Section 2.1 of the Purchase Agreement and have executed this Agreement or have acceded to this
Agreement and the Purchase Agreement in accordance with Section 2.1 of the Purchase Agreement. To
the extent any of the Persons included in the definition of Sellers in accordance with the Purchase
Agreement cease to be included in such definition on or prior to the Closing Date, such Persons
shall automatically be excluded from the definition of Stockholder under this Agreement and shall
immediately cease to be parties to this Agreement.




          “Subsidiary” or “Subsidiaries” shall mean, with respect to any Person, (i) any
corporation more than 50% of whose stock of any class or classes having by the terms thereof
ordinary voting power to elect a majority of the directors of such corporation (irrespective of
whether or not at the time stock of any class or classes of such corporation shall have or might
have voting power by reason of the happening of any contingency) is owned by such Person directly
or indirectly through one or more Subsidiaries of such Person and (ii) any partnership,
association, joint venture or other entity in which such Person directly or indirectly through one
or more Subsidiaries of such Person has more than a 50% equity interest.




          “Suspension Notice” shall have the meaning set forth in Section 5.1(b).




          “Suspension Period” shall have the meaning set forth in Section 5.1(b).




          “Terminated Director” shall mean any Director (a) who was terminated for individual
grounds in accordance with Chapter 7, Section 2 of the Finnish Employment Contracts Act or (b)
dismissed without notice due to Director’s willful acts which seriously hurt the interests of the
Company or its Subsidiaries, or (c) who gives a termination notice due to a reason not attributable
to a material breach by the Company or such Subsidiary of any employment agreement between such
Director and the Company or such Subsidiary.




          “Transfer” shall have the meaning set forth in Section 2.1(a) of this Agreement.




          “US Stockholders” shall mean those Stockholders with one asterisk (*) or two asterisks
(**) set forth next to each of their names on Schedule I attached hereto.





5









 








ARTICLE II




TRANSFER OF SECURITIES



     Section 2.1 Restrictions.



          (a) No Director shall, voluntarily or involuntarily, directly or indirectly, sell, assign,
donate, hypothecate, pledge, encumber, grant a security interest in or in any other manner
transfer, any Securities, in whole or in part, or any other right or interest therein, or enter
into any transaction which results in the economic equivalent of a transfer to any Person (each
such action, a “Transfer”), except pursuant to a Permitted Transfer.




          (b) From and after the date hereof, all certificates or other instruments representing
Securities held by each Director shall bear a legend which shall state:





	 	 	“The sale, transfer, hypothecation, assignment, pledge, encumbrance or other
disposition of this share certificate and the shares of Common Stock represented
hereby are restricted by and are subject to all of the terms, conditions and
provisions of that certain Amended and Restated Stockholders Agreement, dated June
29, 2011, as amended from time to time, by and between the Company and the
stockholders party thereto, which agreement is on file at the principal office of
the Company.”





          (c) All certificates representing Securities held by each US Stockholder (other than
Securities that have been previously registered and sold pursuant to an effective registration
statement under the Securities Act) shall bear a legend which shall state:





	 	 	“The securities represented by this certificate have not been registered under the
Securities Act of 1933, as amended, or pursuant to any state securities laws. The
securities have been acquired for investment and may not be sold or transferred
except in compliance with the registration requirements of the Securities Act of
1933, as amended, and applicable state securities laws or pursuant to an exemption
therefrom.”





          (d) All certificates representing Securities held by each Non-US Stockholder (other than
Securities that have been previously registered and sold pursuant to an effective registration
statement under the Securities Act) shall bear a legend which shall state:





“The securities represented by this certificate have not been registered under the
Securities Act of 1933, as amended, or under the applicable securities law of any
state of the United States or any other jurisdiction and may not be offered or sold
within the United States or to, or for the account or benefit of, U.S. persons
except in accordance with the provisions of Regulation S under the Securities Act of
1933, as amended, pursuant to registration under the Securities Act of 1933, as
amended, or pursuant to an available exemption from such registration and no



6









 







hedging transactions may be engaged in with regard to the Common Stock, except in
compliance with the Securities Act of 1933, as amended. Terms used in this
paragraph have the meanings given to them by Regulation S under the Securities Act
of 1933, as amended.”



          (e) Any attempt to Transfer any Security by a Director which is not in accordance with this
Agreement shall be null and void and the Company agrees that it will not cause, permit or give any
effect to any Transfer of any Securities to be made on its books and records unless such Transfer
is permitted by this Agreement and has been made in accordance with the terms hereof.




          (f) Each Director agrees that it will not effect any Transfer of Securities unless such
Transfer is a Permitted Transfer and is made (i) pursuant to an effective registration statement
under the Securities Act or pursuant to an exemption from the registration requirements of the
Securities Act or pursuant to Rule 144 or Rule 144A promulgated under the Securities Act and (ii)
in accordance with all applicable Laws (including, without limitation, all securities Laws).




     Section 2.2 Permitted Transfers.



          (a) Notwithstanding anything to the contrary contained herein and subject to Sections 2.2(b)
and 2.2(c), a Director may at any time effect any of the following Transfers (each a “Permitted
Transfer”, and each transferee of such Director in respect of such Transfer, a “Permitted
Transferee”):





     (i) any Transfer of any or all Securities held by a Director following such Director’s
death by will or intestacy to such Director’s legal representative, heir or legatee;




     (ii) any Transfer of any or all Securities held by a Director as a gift or gifts during
such Director’s lifetime to such Director’s spouse, children, grandchildren or a trust or
other legal entity for the exclusive benefit of such Director or any one or more of the
foregoing;




     (iii) any Transfer of any or all Securities held by a Director to any Affiliate of such
Director; provided, that any such Affiliate shall Transfer such Securities to the
Director from whom the Securities were originally received or acquired within five (5)
calendar days after ceasing to be an Affiliate of such Director;




     (iv) any Transfer, occurring on or after the first (1st) anniversary of the date
hereof, of any or all Common Stock that, together with all prior Transfers of Common Stock
(A) by the transferring Director to the Company pursuant to clause (viii) below and (B) by
the transferring Director or by any transferee of such transferring Director under clause
(ii) or (iii) above, equals not more than 40% of the Common Stock acquired by the
transferring Director pursuant to the Purchase Agreement, as listed opposite such



7









 







Director’s name on Schedule I attached hereto; provided, that at the time of
such Transfer, such Director is not a Terminated Director;




     (v) any Transfer, occurring on or after the second (2nd) anniversary of the date
hereof, of any or all Common Stock that, together with all prior Transfers of Common Stock
(A) by the transferring Director to the Company pursuant to clause (viii) below and (B) by
the transferring Director or by any transferee of such transferring Director under clause
(ii) or (iii) above or pursuant to Section 2.2(a)(iv), equals not more than 80% of the
Common Stock acquired by the transferring Director pursuant to the Purchase Agreement, as
listed opposite such Director’s name on Schedule I attached hereto; provided, that
at the time of such Transfer, such Director is not a Terminated Director;




     (vi) any Transfer, occurring on or after the third (3rd) anniversary of the date
hereof, of any or all of the remaining Securities held by the transferring Director from
time to time; provided, that at the time of such Transfer, such Director is not a
Terminated Director;




     (vii) any Transfer by a Terminated Director, occurring on or after the fifth (5th)
anniversary of the date hereof, of any or all of the remaining Securities held by the
transferring Director from time to time; and




     (viii) any Transfer to the Company of any or all of the Common Stock deposited by a
Director with the Escrow Agent pursuant to the Escrow Agreement, in connection with a claim
for indemnification made by the Company pursuant to the Purchase Agreement.




     (ix) For the avoidance of doubt, restrictions on Transfer by the Terminated Director
set forth in clauses (iv), (v) and (vi) above shall not apply in case the Director (a) is
terminated for grounds other than as provided for in Chapter 7, Section 2 of the Finnish
Employment Contracts Act or dismissed without notice due to Director’s willful acts which
seriously hurt the interests of the Company or its Subsidiaries, or (b) gives a termination
notice due to a reason attributable to a material breach by the Company or such Subsidiary
of any employment agreement between such Director and the Company or such Subsidiary.



          (b) In any Transfer referred to above in clauses (i), (ii) or (iii) of Section 2.2(a), the
Permitted Transferee shall agree in writing to be bound by all of the provisions of this Agreement,
shall execute and deliver to the Company a counterpart to this Agreement, and shall hold all such
Securities as a “Director” hereunder as if such Permitted Transferee was an original signatory
hereto and shall be deemed to be a party to this Agreement.




          (c) Notwithstanding anything to the contrary contained in this Agreement, none of the
Directors shall sell any Securities other than during any period when the directors and officers of
the Company and its Subsidiaries are not prohibited from selling Securities






8









 







pursuant to the written policies and procedures of the Company governing transfers of
Securities by such officers and directors as may be in effect from time to time and as such
policies and procedures are otherwise applicable to any such Director.




     Section 2.3 Selling Restriction.



          (a) None of the Other Stockholders shall, voluntarily or involuntarily, directly or
indirectly, Transfer any Securities, in whole or in part, or any other right or interest therein,
or enter into any transaction which results in the economic equivalent of a Transfer to any Person
during the three (3)-month period following the Closing Date, except pursuant to Section 2.3(b).




          (b) The Sellers’ Representatives (as such term is defined in the Purchase Agreement), on
behalf of all Other Stockholders who desire to sell any Registrable Securities during three
(3)-month period following the Closing Date, shall inform the Company in writing no later than on
the Closing Date of the number of shares that all Other Stockholders desire to sell during such
period, which sales shall be conducted in an orderly fashion through a single broker acting as
agent for the Other Stockholders. The Company shall use its commercially reasonable efforts to
introduce such Other Stockholders to a broker-dealer or market maker satisfactory to the Sellers’
Representatives (it being agreed that each of Deutsche Bank and Morgan Stanley are satisfactory)
that can sell, as agent for the Other Stockholders, such Common Stock pro rata into the market upon
receiving instructions from the Sellers’ Representatives regarding such sale and at such time as
such broker-dealer or market maker deems appropriate and advisable, in light of then current stock
market conditions and in accordance with the instructions received from the Sellers’
Representatives, provided that (i) the sales represent less than 20% of the trading volume of the
Common Stock on any trading day, (ii) all sales on a single trading day are made using one broker
and (iii) the sales are made at times and on days that are determined by the Sellers’
Representatives. The Other Stockholders shall pay all the fees, expenses and commissions of such
broker-dealers and market makers. After the expiration of such three (3)-month period, each Other
Stockholder shall be free to sell any Common Stock in a manner deemed appropriate by such Other
Stockholder and in compliance with this Agreement and applicable laws.




ARTICLE III




REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS



     Section 3.1 Representations and Warranties of the Stockholders. Each Stockholder
(provided that the representations and warranties in Section 3.1(b) below are hereby made
only by the Directors) hereby severally represents and warrants to the Company as follows:



          (a) Neither the execution and delivery by such Stockholder of this Agreement, nor the
consummation of the transactions contemplated hereby, nor compliance by such Stockholder with any
of the provisions hereof, will conflict with, or result in any violation of or default under, or
give rise to a right of termination, cancellation or acceleration of any obligation or loss of a
material benefit under, (i) any judgment or law applicable to such Stockholder, (ii)






9









 







any contract to which such Stockholder is a party or by which any of its assets or property
are bound, or (iii) the constitutional documents of such Stockholder.




          (b) Each of the Directors understands, with respect to the Common Stock being issued to such
Director pursuant to the terms of the Purchase Agreement, that (i) the offer, sale and distribution
of such Common Stock has not been registered under the Securities Act or the securities or “blue
sky” laws of any jurisdiction and such Common Stock is issued by reason of specific exemptions from
registration under the provisions thereof which depend, in part, upon the investment intent of such
Director and upon the representations made by such Director in this Agreement, (ii) such Common
Stock cannot be offered, sold or transferred unless it is registered and/or qualified under the
Securities Act and any other applicable securities and “blue sky” laws, or is exempt from such
qualification or registration, and the provisions of this Agreement have been complied with, (iii)
there is no assurance that any exemption from registration under the Securities Act and any
applicable state or “blue sky” laws or regulations will be available, or if available, that such
exemption will allow such Director to dispose of or otherwise Transfer any or all of such Common
Stock in the amounts or at the times such Director may propose, (iv) the Company has no obligation
or present intention of registering such Common Stock, and (v) the Company is relying upon the
representations, warranties and agreements made by such Director in this Agreement.




          (c) Such Stockholder is familiar with the terms and provisions of this Agreement. Such
Stockholder hereby represents and acknowledges that it has reviewed this Agreement in its entirety,
has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully
understands all provisions of this Agreement. Such Stockholder hereby agrees to be bound by all of
the terms and provisions of this Agreement applicable to such Stockholder.




          (d) Such Stockholder (i) in case of a US Stockholder, has such knowledge, sophistication and
experience in business and financial matters that it is capable of evaluating the merits and risks
of the transactions contemplated by this Agreement; and (ii) is able to bear the economic risk of
the investment in the Common Stock for an indefinite period of time.




          (e) Unless one asterisk (*) or two asterisks (**) is set forth next to such Stockholder’s name
on Schedule I attached hereto, such Stockholder is not a “US Person” as defined in Rule 902 of
Regulation S.




     Section 3.2 Additional Representations and Warranties of the US Stockholders. In
addition to the representations and warranties set forth in Section 3.1, each US Stockholder hereby
severally represents and warrants to the Company as follows:



          (a) Such US Stockholder is acquiring the Common Stock for its own account for investment and
not with a view to, or offer or sale in connection with, any distribution thereof or with any
present intention of offering or selling or otherwise disposing of such Common Stock in violation
of U.S. federal or state securities Laws.







10









 








          (b) Such US Stockholder represents that neither the Company nor any Person acting on its
behalf, has offered to sell or sold the Common Stock (or any other Securities of the Company) to
such US Stockholder by means of any form of general solicitation or general advertising.




          (c) Such US Stockholder (i) has been provided with access to all information concerning the
Common Stock, the Company and its Subsidiaries, as such US Stockholder has requested and has had an
opportunity to ask questions of, and to receive answers from, management of the Company and to
obtain such additional information concerning the Common Stock, the Company and its Subsidiaries as
such US Stockholder deems necessary in connection with its acquisition of the Common Stock; and
(ii) fully understands the nature, scope and duration of the limitations applicable to the Common
Stock.




          (d) At the time such US Stockholder was offered the Common Stock, and as of the date hereof
and as of the Closing Date such US Stockholder was and will be, either (i) an “accredited investor”
within the meaning of Rule 501 of Regulation D under the Securities Act (as amended by the
Dodd-Frank Wall Street Reform and Consumer Protection Act), and the Company is relying upon such
representation and warranty or (ii) a Non-Accredited US Stockholder and received or will receive
the information specified in Rule 502(b) under the Securities Act.




          (e) Such US Stockholder is not party to any contract or agreement, including any voting trust
or other voting arrangement, whereby any of the Common Stock or any interest therein is to be
offered, sold, assigned, pledged, hypothecated or otherwise transferred.




     Section 3.3 Additional Representations and Warranties of the Non-US Stockholders. In
addition to the representations and warranties set forth in Section 3.1, each Non-US Stockholder
hereby severally represents and warrants to the Company as follows:



          (a) Such Non-US Stockholder (i) has his, her or its principal address outside the United
States, and (ii) was located outside the United States at the time any offer to sell the Common
Stock was made to such Non-US Stockholder and at the Closing.




          (b) Such Non-US Stockholder understands, certifies and agrees that such Non-US Stockholder (i)
is not a U.S. person (as defined in Rule 902(k) under the Securities Act) and is not acquiring the
Common Stock for the account or benefit of any U.S. person, (ii) is acquiring the Common Stock in
an offshore transaction within the meaning of and in accordance with Rules 901 and 903 of
Regulation S (“Regulation S”) promulgated under the Securities Act, (iii) is not acquiring,
and has not entered into any discussions regarding such Non-US Stockholder’s acquisition of, the
Common Stock while such Non-US Stockholder was in the United States or any of its territories or
possessions, (iv) is familiar with the rules and restrictions set forth in Regulation S and has not
undertaken and will not undertake any activity for the purpose of, or that could reasonably be
expected to have the effect of, conditioning the market in the United States for the Common Stock,
(v) will not engage in hedging transactions with regard to the Common Stock, except in compliance
with the Securities Act, and (vi) is not a






11









 







“distributor” within the meaning Rule 902(d) under the Securities Act with respect to the
Common Stock.




ARTICLE IV




Intentionally Omitted.



ARTICLE V




REGISTRATION OF THE REGISTRABLE SECURITIES; OTHER MATTERS



     Section 5.1 Shelf Registration Statement.



          (a) Not later than one (1) Business Day after the Closing Date, each of the Other Stockholders
shall furnish to the Company a completed Selling Securityholder Questionnaire, the form of which is
attached hereto as Exhibit A (the “Selling Securityholder Questionnaire”), containing the
information required for use in the preparation of the Shelf Registration Statement. The Company
shall prepare the Shelf Registration Statement reflecting, among other things, the information
contained in the Selling Securityholder Questionnaires provided to the Company by the Other
Stockholders not later than one Business Day after the Closing Date. If during the Shelf
Registration Period (as defined below) any event with respect to either an Other Stockholder or any
Affiliate of an Other Stockholder shall occur which is required at that time to be described in the
Shelf Registration Statement or the prospectus included therein and is not already so described
therein, such Other Stockholder shall promptly notify the Company. Not later than three (3)
Business Days after the Closing Date, the Company shall file with the SEC the Shelf Registration
Statement to cover the registration of the Registrable Securities for resale by the Other
Stockholders that have furnished to the Company the Selling Securityholder Questionnaire not later
than one Business Day after the Closing Date, and the Company shall use its commercially reasonable
efforts to cause the Shelf Registration Statement to be declared effective by the SEC. Thereafter,
the Company shall use its commercially reasonable efforts to keep the Shelf Registration Statement
continuously effective under the Securities Act until the earlier of (i) when each Other
Stockholder is able to sell all of their Registrable Securities without volume, manner of sale and
availability of current public information restrictions under Rule 144, and (ii) when each Other
Stockholder has sold all of its Registrable Securities pursuant to such Shelf Registration
Statement (the “Shelf Registration Period”). Notwithstanding the foregoing, the Company
shall have the right to (i) suspend the use of the Shelf Registration Statement from the time of
the filing by the Company of any post-effective amendment thereto until such time as such
post-effective amendment has been declared effective by the SEC, or (ii) delay the effectiveness of
the Shelf Registration Statement if the financial statements or other information of The Switch
Engineering Oy or the Other Stockholders required to be included therein pursuant to the applicable
requirements of the Securities Act are not available, or (iii) suspend the use of, the Shelf
Registration Statement for not more than forty-five (45) Business Days in the aggregate during any
12-month period (a “Suspension Period”) if, in the case of clause (iii), (x) the Company is
engaged in a material






12









 







activity or transaction or preparations for a material activity or transaction that the
Company desires to keep confidential for business reasons and the Company determines in good faith
that the disclosure of such activity, transaction or preparations would otherwise be required by
disclosure requirements under the Securities Act, and (y) the Company provides the Other
Stockholders with written notice of such suspension (a “Suspension Notice”). The Company
shall use its commercially reasonable efforts to have the Shelf Registration Statement declared
effective by the SEC and to lift any such suspension as promptly as practicable after a condition
specified in clause (ii) or (iii)(x) above is no longer applicable, as applicable. The
Stockholders agree to treat and keep the existence of any such delay or suspension confidential.
If the Company suspends the use of the Shelf Registration Statement, the Other Stockholders shall
immediately cease Transfers of shares pursuant thereto upon the receipt of the Suspension Notice.
The Company shall promptly notify the Other Stockholders when the Shelf Registration Statement may
once again be used. Prior to the expiration of the Shelf Registration Period, each Other
Stockholder shall notify the Company of each Transfer of Registrable Securities within ten Business
Days of such Transfer. Not later than one (1) Business Day after the Shelf Registration Statement
is declared effective by the SEC, the Company shall cause its counsel (which may be its internal
counsel) to issue a blanket opinion (the “Blanket Opinion”) to the Company’s transfer agent
stating that the Registrable Securities covered by the Shelf Registration Statement are subject to
an effective registration statement and, when transferred in a transaction covered by the Shelf
Registration Statement, can be issued free of any restrictive legend(s).




          (b) During the Shelf Registration Period, the Company shall, other than during a Suspension
Period, (i) as promptly as practicable, prepare and file with the SEC such post-effective
amendments to the Shelf Registration Statement, as may be necessary to keep the Shelf Registration
Statement continuously effective and available for the resale of the Registrable Securities by the
Other Stockholders during the Shelf Registration Period; (ii) cause the related prospectus to be
supplemented by any required prospectus supplement, and as so supplemented to be filed with the SEC
pursuant to Rule 424 under the Securities Act; and (iii) use its commercially reasonable efforts to
comply with the provisions of the Securities Act applicable to the disposition of Registrable
Securities covered by the Shelf Registration Statement during the Shelf Registration Period in
accordance with the intended methods of disposition by the Other Stockholders set forth in such
Shelf Registration Statement as so amended or such prospectus as so supplemented. The Company
shall use its commercially reasonable efforts to respond to any and all comments received from the
SEC with respect to the Shelf Registration Statement and to provide to the Sellers’ Representatives
on behalf of the Other Stockholders true and complete copies of all correspondence from and to the
SEC relating to the Shelf Registration Statement. The Stockholders agree to treat and keep such
comments (and the existence of any such comments) confidential until such time as the comments are
made publicly available by the SEC.




          (c) The Company shall use its commercially reasonable efforts to obtain the withdrawal, at the
earliest possible time, of an order suspending the effectiveness of the Shelf Registration
Statement, if applicable.







13









 








          (d) The Other Stockholders acknowledge that the Company is required to maintain the accuracy
of the information included in the Shelf Registration Statement, including information contained in
the prospectus included therein. To the extent required to comply with the Securities Act, the
Other Stockholders shall promptly furnish to the Company any additional information required to
correct and update any previously furnished information or required so that the Shelf Registration
Statement and the prospectus included therein shall not contain, with respect to such Other
Stockholder, an untrue statement of material fact or omit to state a fact necessary to make the
statements therein (in the case of any prospectus, prospectus supplement or Free Writing
Prospectus, in light of the circumstances under which they were made) not misleading.




     Section 5.2 Registration Procedures.



          (a) In connection with the Company’s obligations with respect to the registration of the
Registrable Securities, the Company shall during the Shelf Registration Period:




               (i) promptly notify the Other Stockholders and confirm such advice in writing, (A) of the
issuance by the SEC of any stop order suspending the effectiveness of the Shelf Registration
Statement or the initiation or threatening of any proceedings for that purpose, or (B) that the
Shelf Registration Statement or prospectus included therein contains an untrue statement of a
material fact or omits to state any material fact required to be stated therein or necessary to
make the statements therein (in the case of the prospectus, in light of the circumstances under
which they were made) not misleading; and



               (ii) unless available on EDGAR, deliver to the Other Stockholders as many copies of the
prospectus relating to the Registrable Securities and any amendment or supplement thereto in
conformity with the requirements of the Securities Act, as such Other Stockholders may reasonably
request, to permit such Other Stockholders to satisfy the prospectus delivery requirements of the
Securities Act.



          (b) In the event that the Company would be required, pursuant to Section 5.2(a)(i)(B), to
notify the Other Stockholders, the Company shall prepare and furnish to the Other Stockholders a
reasonable number of copies of a prospectus supplemented or amended so that, as thereafter
delivered to purchasers of the Registrable Securities, such prospectus shall not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein (in the case of any prospectus, prospectus supplement or
Free Writing Prospectus, in light of the circumstances under which they were made) not misleading.
The Other Stockholders agree that upon receipt of any notice from the Company pursuant to Section
5.2(a)(i)(B), they shall forthwith discontinue the disposition of the Registrable Securities until
they shall have received copies of such amended or supplemented prospectus, and if so directed by
the Company, the Other Stockholders shall deliver to the Company all copies, other than permanent
file copies, then in their possession of the prospectus covering such Registrable Securities at the
time of receipt of such notice.



14









 





          (c) The Company may require the Other Stockholders to furnish to the Company such information
regarding the Other Stockholders and their intended method of distribution of the Registrable
Securities as the Company may from time to time reasonably request in writing, but only to the
extent that such information is required in order to comply with the Securities Act;
provided that the Company shall not be required to amend or supplement the Shelf
Registration Statement or the prospectus contained therein to permit the resale by the Other
Stockholders of Registrable Securities in an underwritten offering. Each Other Stockholder agrees
to notify the Company as promptly as practicable of any inaccuracy or change in information
previously furnished by such Other Stockholder to the Company or of the occurrence of any event, in
either case as a result of which any prospectus relating to such registration contains or would
contain an untrue statement of a material fact regarding such Other Stockholder or such Other
Stockholder’s intended method of distribution of such Registrable Securities or omits or would omit
to state any material fact regarding such Other Stockholder or such Other Stockholder’s intended
method of distribution of such Registrable Securities required to be stated therein or necessary to
make the statements therein (in the case of any prospectus, prospectus supplement or Free Writing
Prospectus, in light of the circumstances under which they were made) not misleading, and promptly
to furnish to the Company any additional information required to correct and update any previously
furnished information or required so that such prospectus shall not contain, with respect to such
Other Stockholder or the distribution of such Registrable Securities, an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein (in the case of any prospectus, prospectus supplement or Free Writing
Prospectus, in light of the circumstances under which they were made) not misleading.




     Section 5.3 Indemnification; Contribution.



          (a) The Company agrees to indemnify and hold harmless each Other Stockholder holding
Registrable Securities, the Affiliates, directors, officers, employees, members, managers and
agents of each such Other Stockholder and each Person who controls any such Other Stockholder
within the meaning of either the Securities Act or the Exchange Act from and against any and all
losses, claims, damages, liabilities and expenses (or actions in respect thereof), including,
without limitation, any legal or other expenses, reasonably incurred in connection with defending
or investigating any such action or claim, to which they or any of them may become subject insofar
as such losses, claims, damages, liabilities and expenses (or actions in respect thereof) arise out
of or are based upon any violation of the Securities Act, Exchange Act or state securities Laws, or
upon any untrue statement or alleged untrue statement of a material fact contained in the Shelf
Registration Statement as originally filed or in any amendment thereof, or the Disclosure Package,
or any preliminary, final or summary prospectus or Free Writing Prospectus, or in any amendment
thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements
therein (in the case of the Disclosure Package, or any preliminary, final or summary prospectus or
Free Writing Prospectus, in light of the circumstances under which they were made) not misleading;
provided, however, that the Company will not be liable in any case to the extent that any such
loss, claim, damage, liability






15









 







or expense arises (i) out of or is based upon any such untrue statement or alleged untrue
statement or omission or alleged omission made therein in reliance upon and in conformity with
written information furnished to the Company by or on behalf of any such Other Stockholder
specifically for inclusion therein including, without limitation, any notice and questionnaire,
(ii) out of sales of Common Stock made during a Suspension Period or (iii) to the extent that a
prospectus or Free Writing Prospectus relating to the Registrable Securities was required to be
delivered by the Other Stockholder under the Securities Act, out of or is caused by such Other
Stockholder’s failure to deliver a copy of any preliminary, final or summary prospectus or Free
Writing Prospectus, or any amendments thereof or supplements thereto, at or prior to the written
confirmation of the sale of Registrable Securities and if the prospectus or the Free Writing
Prospectus, or any amendments thereof or supplements thereto, would have cured the defect giving
rise to such losses, claims, damages, liabilities and expenses, and after the Company has furnished
such Indemnified Party with a sufficient number of copies of the same.




          (b) Each Other Stockholder severally (and not jointly) agrees to indemnify and hold harmless
the Company and each of its Affiliates, directors, employees, members, managers and agents and each
Person who controls the Company within the meaning of either the Securities Act or the Exchange Act
from and against any and all losses, claims, damages or liabilities to which they or any of them
may become subject insofar as such losses, claims, damages or liabilities arise out of or are based
upon any violation of the Securities Act, Exchange Act or state securities Laws, upon any untrue
statement or alleged untrue statement of a material fact contained in the Shelf Registration
Statement as originally filed or in any amendment thereof, or in the Disclosure Package, or any
Other Stockholder Free Writing Prospectus, preliminary, final or summary prospectus included in any
such registration statement, or in any amendment thereof or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein (in the case of the Disclosure Package,
or any preliminary, final or summary prospectus or Free Writing Prospectus, in light of the
circumstances under which they were made) not misleading, to the extent, but only to the extent,
that any such untrue statement or alleged untrue statement or omission or alleged omission was made
in reliance on and in conformity with any written information relating to such Other Stockholder
furnished to the Company by or on behalf of such Other Stockholder specifically for inclusion
therein; provided, however, that the total amount to be indemnified by such Other
Stockholder pursuant to this Section 5.3(b) shall be limited to the net proceeds (after deducting
underwriters’ discounts and commissions, if any) received by such Other Stockholder upon the sale
of the Registrable Securities to which such registration statement or prospectus relates.




          (c) Promptly after receipt by an indemnified party under this Section 5.3 of notice of the
commencement of any action or proceeding (including governmental investigation), such indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under this
Section 5.3, notify the indemnifying party in writing of the commencement thereof; but the failure
so to notify the indemnifying party will not relieve it from liability under Section 5.3(a) or
Section 5.3(b) unless and to the extent such action and such failure results in material prejudice
to the indemnifying party. If any such claim, action or proceeding shall be






16









 







brought against the indemnified party and it notifies the indemnifying party thereof, the
indemnifying party shall be entitled to participate therein and, to the extent that it shall wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party, and, except as provided in the next
sentence, after notice from the indemnifying party to such indemnified party of its election to so
assume the defense thereof, the indemnifying party shall not be liable to such indemnified party
for any legal expenses of other counsel or any other expenses subsequently incurred by such
indemnified party in connection with the defense thereof. Notwithstanding the indemnifying party’s
rights in the prior sentence, the indemnified party shall have the right to employ its own counsel
(and one local counsel), and the indemnifying party shall bear the reasonable fees, costs and
expenses of such separate counsel satisfactory to the indemnifying party if (i) the use of counsel
chosen by the indemnifying party to represent the indemnified party would, in the reasonable
judgment of the indemnified party, present such counsel with a conflict of interest; (ii) the
actual or potential defendants in, or targets of, any such action include both the indemnified
party and the indemnifying party and the indemnified party, based on advice of counsel to the
indemnified party, shall have reasonably concluded that there may be legal defenses available to it
and/or other indemnified parties which are different from or additional to those available to the
indemnifying party; (iii) the indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified party within a reasonable time
after written notice of the institution of such action; or (iv) the indemnifying party shall
authorize the indemnified party to employ separate counsel at the expense of the indemnifying
party. No indemnifying party shall, in connection with any one action or separate but
substantially similar or related actions in the same jurisdiction arising out of the same general
circumstances or allegations, be liable for the reasonable fees and expenses of more than one
separate firm of attorneys (in addition to any local counsel) for all indemnified parties. An
indemnifying party shall not be liable under this Section 5.3 to any indemnified party regarding
any settlement or compromise or consent to the entry of any judgment with respect to any pending or
threatened claim, action, suit or proceeding in respect of which indemnification or contribution
may be sought hereunder (whether or not the indemnified parties are actual or potential parties to
such claim or action) unless such settlement, compromise or consent is consented to by such
indemnifying party in writing. No indemnifying party, in the defense of any such claim or
litigation, shall, except with the written consent of each indemnified party, consent to entry of
any judgment or enter into any settlement or compromise unless such settlement or compromise (x)
includes an unconditional release of such indemnified party from all liability on claims that are
the subject matter of such proceeding and (y) does not include any statement as to or any admission
of fault, culpability or a failure to act by or on behalf of any indemnified party.




          (d) In the event that the indemnity provided in Section 5.3(a) or Section 5.3(b) is
unavailable to an indemnified party for any reason, then each applicable indemnifying party agrees
to contribute to the aggregate losses, claims, damages and liabilities (including, without
limitation, legal or other expenses reasonably incurred in connection with investigating or
defending same) to which such indemnifying party may be subject in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand and the






17









 







Other Stockholders on the other hand from the transactions contemplated by the Purchase
Agreement and this Agreement. If, however, this allocation is not permitted by applicable law, then
each indemnifying party shall contribute to the amount paid or payable by such indemnified party as
a result of such loss, claim, damage or liability, or action in respect thereof, in such proportion
as shall be appropriate to reflect the relative benefits received by the Company on the one hand
and the Other Stockholders on the other hand from the transactions contemplated by the Purchase
Agreement and the relative fault of the indemnifying party on the one hand and the indemnified
party on the other in connection with the statements or omissions which resulted in such losses,
claims, damages or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the indemnifying party
on the one hand or the indemnified party on the other and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The
parties agree that it would not be just and equitable if contribution pursuant to this Section
5.3(d) were determined by pro rata allocation (even if the Other Stockholders or any agents or
underwriters or all of them were treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations referred to above in this
Section 5.3(d). The amount paid or payable by an indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to above in this Section
5.3(d) shall be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 5.3(d), no Other Stockholder shall be required to
contribute any amount in excess of the net proceeds (after deducting underwriters’ discounts and
commissions, if any) received by such Other Stockholder upon the sale of the Registrable
Securities. Notwithstanding the provisions of this Section 5.3(d), no Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation.




          (e) The agreements contained in this Section 5.3 shall survive the sale of the Registrable
Securities by the Other Stockholders and shall remain in full force and effect, regardless of any
termination or cancellation of this Agreement after the Closing.




     Section 5.4 Other Matters.



          (a) The Company covenants that for so long as the Company is otherwise required to maintain
the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act, the Company
shall use its commercially reasonable efforts to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the
Company after the Closing pursuant to the Exchange Act and to submit electronically and post on its
corporate Web site every Interactive Data File required to be submitted and posted pursuant to Rule
405 of Regulation S-T in connection therewith. If the Company is not then required to file reports
pursuant to the Exchange Act, it shall use its commercially reasonable efforts to prepare and
furnish to the Stockholders and make publicly






18









 







available in accordance with Rule 144(c) such information as is required for the Stockholders
to sell the Common Stock under Rule 144 promulgated under the Securities Act. The Company further
covenants that it shall use its commercially reasonable efforts to take such further action as any
Stockholder may reasonably request, to the extent required from time to time to enable the
Stockholders to sell such Common Stock without registration under the Securities Act within the
requirements of the exemption provided by Rule 144.




          (b) Upon the calculation of the number of shares of Common Stock issuable to the Directors and
Other Stockholders in accordance with Section 4.2(a) of the Purchase Agreement, the Company and the
Sellers’ Representatives shall complete Schedule I attached hereto by listing the number of shares
of Common Stock to be issued to each Director and Other Stockholder at the Closing opposite such
Stockholder’s name on Schedule I attached hereto.




ARTICLE VI




MISCELLANEOUS



     Section 6.1 Entire Agreement. This Agreement, including the schedules hereto and any
other documents referred to herein which form a part hereof, contains the entire understanding of
the parties hereto with respect to the subject matter contained herein and therein. This Agreement
supersedes all prior agreements and understandings between the parties with respect to such subject
matter.



     Section 6.2 Table of Contents; Captions. The table of contents and the Article and
Section captions used herein are for reference purposes only, and shall not in any way affect the
meaning or interpretation of this Agreement.



     Section 6.3 Counterparts. This Agreement may be executed in two or more counterparts,
all of which taken together shall constitute one instrument.


     Section 6.4 Notices. Any notice or other communication required or permitted under this
Agreement, which all shall be in the English language, shall be deemed to have been duly given (i)
five (5) Business Days following deposit in the mails if sent by registered or certified mail,
postage prepaid, (ii) when sent, if sent by facsimile transmission, if receipt thereof is confirmed
by telephone, (iii) when delivered, if delivered personally to the intended recipient, (iv) two (2)
Business Days following deposit with a nationally recognized overnight courier service and (v)
e-mail with e-mail acknowledgement of receipt to the party in question, in each case addressed as
follows:



If to the Company, to:



American Superconductor Corporation

64 Jackson Road

Devens, MA 01434

Attention: John Powell, General Counsel

Telephone: 978-842-3539




19









 




Facsimile: 978-842-3530

E-mail: jpowell@amsc.com



and if to any of the Stockholders, to the addresses, facsimile numbers or e-mail addresses set
forth opposite each of their names on Schedule I attached hereto; or such other addresses, numbers
or e-mail addresses as shall be furnished in writing by any such party.




     Section 6.5 Successors and Assigns. This Agreement shall be binding upon and inure to
the benefit of the Company, the Stockholders and their respective successors and Permitted
Transferees. Any or all of the rights of a Stockholder under this Agreement may be assigned or
otherwise conveyed by any Stockholder only in connection with a Transfer of Securities which is in
compliance with this Agreement.



     Section 6.6 Governing Law. The interpretation and construction of this Agreement, and
all matters relating hereto, shall be governed by the laws of the State of Delaware, without regard
to the principles of conflicts of laws thereof.



     Section 6.7 Resolution of Disputes. All disputes under this Agreement shall be
resolved in accordance with the procedures described in Section 12.9 of the Purchase Agreement.



     Section 6.8 Third Party Beneficiaries. Each party hereto intends that this Agreement
shall not benefit or create any right or cause of action in or on behalf of any Person other than
the parties hereto.



     Section 6.9 Amendments; Waivers. (a) No provision of this Agreement contained in
Article II hereof or in the definitions of any defined terms used in Article II may be amended,
modified or waived without the prior written consent of the Company and the holders of more than
fifty percent (50%) of the issued and outstanding Securities held by the Directors, collectively;
provided, that no amendment, modification or waiver of any such provisions shall adversely
affect the rights or obligations of any Director (i) in a manner different from any other Director
and disproportionately adverse to any Director or (ii) specifically granted to or imposed upon such
Director but not to or upon all other Directors, in each case without such Director’s prior written
consent.



          (b) No provision of this Agreement contained in Sections 5.1 to 5.3 hereof or in the
definitions of any defined terms used in such Sections may be amended, modified or waived without
the prior written consent of the Company and the holders of more than fifty percent (50%) of the
issued and outstanding Securities held by the Other Stockholders, collectively; provided,
that no amendment, modification or waiver of any such provisions shall adversely affect the rights
or obligations of any Other Stockholder (i) in a manner different from any other Other Stockholder
and disproportionately adverse to any Other Stockholder or (ii) specifically granted to or imposed
upon such Other Stockholder but not to or upon all other Other Stockholders, in each case without
such Other Stockholder’s prior written consent.







20









 








          (c) Except for the provisions of Article II and the definitions of any defined terms used
therein, which shall be governed by Section 6.9(a), and the provisions of Sections 5.1 to 5.3 and
the definitions of any defined terms used therein, which shall be governed by Section 6.9(b), no
other provision of this Agreement and the definitions of any defined terms used therein may be
amended, modified or waived without the prior written consent of the Company and the holders of
more than fifty percent (50%) of the issued and outstanding Securities held by the Stockholders,
collectively; provided, that no amendment, modification or waiver of any such provisions
shall adversely affect the rights or obligations of any Stockholder (i) in a manner different from
any other Stockholder and disproportionately adverse to any Stockholder or (ii) specifically
granted to or imposed upon such Stockholder but not to or upon all other Stockholders, in each case
without such Stockholder’s prior written consent.




          (d) Notwithstanding anything set forth in this Section 6.9 to the contrary, (i) no amendment
or modification to, or deletion of, this Section 6.9 shall be effective unless unanimously
approved by all of the Stockholders, (ii) the addition of parties to this Agreement in accordance
with its terms shall not be deemed to be an amendment, modification or waiver requiring the consent
of any Stockholder, and (iii) the completion of Schedule I by the Company and the Sellers’
Representatives in accordance with Section 5.4(b) shall not be deemed to be an amendment,
modification or waiver requiring the consent of any Stockholder.




     Section 6.10 No Strict Construction. The parties hereto have participated jointly in
the negotiation and drafting of this Agreement. In the event any ambiguity or question of intent
or interpretation arises, this Agreement shall be construed as if drafted jointly by all parties
hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provision of this Agreement.



     Section 6.11 Specific Performance. Each of the Company and each Stockholder agrees
that irreparable damages would occur to the Company or such Stockholder, as the case may be, if any
of the provisions of this Agreement were not performed in accordance with their specific terms or
were otherwise breached. It is accordingly agreed that each of the Company and each Stockholder
shall be entitled to seek an injunction or injunctions to prevent actual breaches of this Agreement
by the Company or the Stockholders, as the case may be, and to enforce specifically the terms and
provisions hereof in any court of competent jurisdiction, in addition to having any other remedies
to which the Company or such Stockholder is entitled at law or in equity and without the necessity
of proving damages or posting a bond or other security.



     Section 6.12 Expenses. The Company shall bear all fees and expenses incurred in
connection with the performance of its obligations under Sections 5.1 and 5.2.



     Section 6.13 Termination. This Agreement shall automatically terminate and be void ab
initio immediately upon termination of the Purchase Agreement in accordance with its terms.



* * *








21









 








          IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first set
forth above.




	 	 	 	 	 
	 	AMERICAN SUPERCONDUCTOR CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 














 





	 	 	 

	POWER FUND I KY

	 	POWER FUND II KY
	 
	 	 
	 

	 	 
	Veijo Karppinen

	 	Jarmo Saaranen
	 
	 	 
	VACON PLC
	 	 
	 
	 	 
	 

	 	 
	Vesa Laisi
	 	 
	 
	START FUND I KY
	 	 
	 
	 	 
	 

	 	 
	Henri Grundstén

	 	Jukka-Pekka Mäkinen
	 
	 	 
	 

	 	 
	Dag Sandås

	 	Pertti Kurttila
	 
	 	 
	 

	 	 
	Reijo Takala

	 	Jari Kemppi
	 
	 	 
	 

	 	 
	Anders Troedson

	 	Jukka Rantanen
















 





Veijo Karppinen

As attorney-in-fact for the following parties hereto:




	 	 	 

	Ahonen Mikko

	 	Ahvo Risto
	 
	 	 
	Ala Milla

	 	Alamäki Jarmo
	 
	 	 
	Alho Timo

	 	Autio Pekka
	 
	 	 
	Backlund Marcus

	 	Baoquan Liu
	 
	 	 
	Black Paul

	 	Groshev Sergey
	 
	 	 
	Hao Jixiang

	 	Heinonen Seppo
	 
	 	 
	Hermunen Pekka

	 	Hertsbacka Henna
	 
	 	 
	Hewitt Simon

	 	Huppunen Jussi
	 
	 	 
	Hämäläinen Mikko

	 	Ikonen Mika
	 
	 	 
	Isotalo Esko

	 	Jaaksi Lilja
	 
	 	 
	Jantunen Mika

	 	Kalervo Pasi
	 
	 	 
	Kankaala Kari

	 	Koiranen Johanna
	 
	 	 
	Korhonen Ari

	 	Koskela Mika
	 
	 	 
	Koskela Pasi

	 	Koskinen Mona
	 
	 	 
	Koskiniemi Kari

	 	Kristola Marko
	 
	 	 
	Laukkanen Jorma

	 	Lewing Raimo
	 
	 	 
	Lipsanen Anssi

	 	Lipsanen Esa
	 
	 	 
	Munkki Marianne

	 	Mäkynen Arto
	 
	 	 
	Mäntylä Mika

	 	Niemelä Hanna
	 
	 	 
	Nummi Ulla-Riitta

	 	Nykänen Päivi
	 
	 	 
	O ́ Reilly Tom

	 	Ollila Harri
	 
	 	 
	Paakkunainen Jussi

	 	Partinen Janne
	 
	 	 
	Pesonen Veli

	 	Pirkola Sami
	 
	 	 
	Pohtola Janne

	 	Puranen Jussi
	 
	 	 
	Pyrhönen Juha

	 	Pyrhönen Olli
	 
	 	 
	Rajala Arita

	 	Ranta Marina
	 
	 	 
	Raunio Mari-Lotta

	 	Reinilä Juha
	 
	 	 
	Rönnlund Kaj

	 	Salmela Marko
	 
	 	 
	Schreiber Dejan

	 	Semikron International GmbH
	 
	 	 
	Silventoinen Pertti

	 	Suutarinen Ari
	 
	 	 
	Söderman Kim

	 	Turku Tuula
	 
	 	 
	Törmänen Pasi

	 	Wainio Sami
	 
	 	 
	Vallinmäki Alpo

	 	Vallinmäki Sari
	 
	 	 
	Vepsäläinen Jari

	 	Westerberg Anders
	 
	 	 
	Yli-Mutka Pekka

	 	Zhao Ti






24









 





Schedule I




STOCKHOLDERS1



Directors




	 	 	 	 	 
	Name of Director	 	Number of Shares	 	Notice Address
	Jukka-Pekka Mäkinen

	 	 	 	Taulutie 12 C, FI-00680 HELSINKI
	 
	 	 	 	 
	Dag Sandås

	 	 	 	Hovioikeudenpuistikko 11 A 10,
FI-65100 VAASA
	 
	 	 	 	 
	Pertti Kurttila

	 	 	 	Radiotie 14, FI-65370 VAASA
	 
	 	 	 	 
	Reijo Takala

	 	 	 	Airopolku 3, FI-40420 JYSKÄ
	 
	 	 	 	 
	Jari Kemppi

	 	 	 	Nikkarinkatu 29, FI-15500 LAHTI
	 
	 	 	 	 
	Jukka Rantanen

	 	 	 	Vasaroisenkatu 3 C, FI-15900 LAHTI
	 
	 	 	 	 
	Anders Troedson**

	 	 	 	19780 W. Imperial Ct., New Berlin, WI 53146, USA





Other Stockholders




	 	 	 	 	 
	Name of Other Stockholder	 	Number of Shares	 	Notice Address
	Power Fund I Ky

	 	 	 	c/o VNT Management Oy, Alatori 1 B,

FI-65100 VAASA
	 
	Semikron International
GmbH

	 	 	 	Sigmundstrasse 200 D-90431
NURENBERG
	 
	Vacon Oyj

	 	 	 	PL 25, FI-65381 VAASA
	 
	Start Fund I Ky (Tesi)

	 	 	 	c/o Suomen Teollisuussijoitus Oy

Kalevankatu 9 A, FI-00100 HELSINKI








 




			
	1	 	(*) indicates such Person is a US Stockholder. (**)
indicates such Person is a Non-Accredited US Stockholder, i.e., a US
Stockholder who is not an “accredited investor” under Rule 501.















 





	 	 	 	 	 
	Name of Other Stockholder	 	Number of Shares	 	Notice Address
	Zhao Ti

	 	 	 	No 1302, unite 1, 58 Building,

YUANYANGTIANDI, Chaoyang, Beijing,

100025,P,R,CHINA
	 
	 	 	 	 
	Kaj Rönnlund

	 	 	 	Villavägen 33, FI-65280 VASA
	 
	 	 	 	 
	Veli Pesonen

	 	 	 	Hallalantie 47, FI-36200 KANGASALA
	 
	 	 	 	 
	Pasi Törmänen

	 	 	 	Satulatie 20, FI-65230 VAASA
	 
	 	 	 	 
	Power Fund II

	 	 	 	c/o VNT Management Oy, Alatori 1 B,

FI-65100 VAASA
	 
	 	 	 	 
	Harri Ollila

	 	 	 	Hirsikalliontie 22 B, FI-02170 ESPOO
	 
	 	 	 	 
	Alpo Vallinmäki

	 	 	 	Gerbyntie 71, FI-65230 VAASA
	 
	 	 	 	 
	Sari Vallinmäki

	 	 	 	Gerbyntie 71, FI-65230 VAASA
	 
	 	 	 	 
	Dejan Schreiber

	 	 	 	Pirckheimerstrasse 49 D-90408

NURENBERG
	 
	 	 	 	 
	Jussi Huppunen

	 	 	 	Tapparakuja 1 B 1, FI-01700 VANTAA
	 
	 	 	 	 
	Jarmo Alamäki

	 	 	 	Välikatu 27, FI-53200 LAPPEENRANTA
	 
	 	 	 	 
	Esko Isotalo

	 	 	 	Raastuvankatu 1 B 21, FI-65100 VAASA
	 
	 	 	 	 
	Arto Mäkynen

	 	 	 	Karhuntie 4 as. 3, FI-65350 VAASA
	 
	 	 	 	 
	Ari Suutarinen

	 	 	 	Huvilatie 26, FI-65230 VAASA
	 
	 	 	 	 
	Marina Ranta

	 	 	 	Levoninkatu 16 as 7, FI-65200 VAASA
	 
	 	 	 	 
	Olli Pyrhönen

	 	 	 	Suokankaankatu 6, FI-53850

LAPPEENRANTA
	 
	 	 	 	 
	Ari Korhonen

	 	 	 	Häyhänniementie 25, FI-53850

LAPPEENRANTA
	 
	 	 	 	 
	Mika Jantunen

	 	 	 	Valokaarenkatu 10 as. 1, FI-65320

VAASA
	 
	 	 	 	 
	Juha Pyrhönen

	 	 	 	Mäyränkatu 31, FI-53850

 LAPPEENRANTA






26









 






	 	 	 	 	 
	Name of Other Stockholder	 	Number of Shares	 	Notice Address
	Tom O ́ Reilly **

	 	 	 	33 North Pepperell Road US-Hollis, NH

03049, USA
	 
	 	 	 	 
	Milla Ala

	 	 	 	Länkitie 10, FI-65230 VAASA
	 
	 	 	 	 
	Marianne Munkki

	 	 	 	Länsirinteentie 28, FI-66510

MERIKAARTO
	 
	 	 	 	 
	Marko Kristola

	 	 	 	Slottintie 23 FI-65280 VAASA
	 
	 	 	 	 
	Marko Salmela

	 	 	 	Kiskottajankuja 2 A 9, FI-02660 ESPOO
	 
	 	 	 	 
	Paul Black

	 	 	 	Room 1907, Tower B, Tianyuangang

Center, No.2C, North Dongsanhuan,

Chaoyang District,100027
	 
	 	 	 	 
	Kim Söderman

	 	 	 	Hiekkaharjuntie 56, FI-02400

KIRKKONUMMI
	 
	 	 	 	 
	Pasi Koskela

	 	 	 	Hevoshaantie 4 E 5, FI-65230 VAASA
	 
	 	 	 	 
	Pekka Yli-Mutka

	 	 	 	Laippakatu 2 C 18, FI-65320 VAASA
	 
	 	 	 	 
	Jorma Laukkanen

	 	 	 	Tanhuantie 10 F, FI-53920 LAPPEENRANTA
	 
	 	 	 	 
	Sami Wainio

	 	 	 	Haapaniementie 8, FI-65370 VAASA
	 
	 	 	 	 
	Jari Vepsäläinen

	 	 	 	Fintrade Mercer 1709 Nan Fung Tower, 173

 Des Voeux Road Central, HONGKONG
	 
	 	 	 	 
	Tuula Turku

	 	 	 	Liljankatu 10, FI-53810 LAPPEENRANTA
	 
	 	 	 	 
	Pertti Silventoinen

	 	 	 	Jänönkatu 5 A, FI-53850

 LAPPEENRANTA
	 
	 	 	 	 
	Pasi Kalervo

	 	 	 	Rantakatu 26 C 37, FI-65100 VAASA
	 
	 	 	 	 
	Hanna Niemelä

	 	 	 	Minkinkatu 21, FI-53850

 LAPPEENRANTA
	 
	 	 	 	 
	Seppo Heinonen

	 	 	 	Rusnarinkatu 19, FI-65230 VAASA
	 
	 	 	 	 
	Janne Pohtola

	 	 	 	Härkäluhdantie 8, FI-66400 LAIHIA
	 
	 	 	 	 
	Juha Reinilä

	 	 	 	Kuokkamiehentie 7, FI-65300 VAASA






27









 






	 	 	 	 	 
	Name of Other Stockholder	 	Number of Shares	 	Notice Address
	Anders Westerberg

	 	 	 	Danilssidsvägen 129, FI-66560

ÖSTERHANKMO
	 
	 	 	 	 
	Johanna Koiranen

	 	 	 	Huutoniementie 55D, FI-65320 VAASA
	 
	 	 	 	 
	Mari-Lotta Raunio

	 	 	 	Luuvantie 1 A 2, FI-02620 ESPOO
	 
	 	 	 	 
	Esa Lipsanen

	 	 	 	Strömbergintie 8 C 80, FI-00380

HELSINKI
	 
	 	 	 	 
	Raimo Lewing

	 	 	 	Puintikuja 6, FI-02620 ESPOO
	 
	 	 	 	 
	Risto Ahvo **

	 	 	 	120 Coliseum Ave. unit 303, Nashua,

03063, NH,USA
	 
	 	 	 	 
	Mika Mäntylä

	 	 	 	Nupputie 16, FI-65280 VAASA
	 
	 	 	 	 
	Sami Pirkola

	 	 	 	Käpypolku 2, FI-65280 VAASA
	 
	 	 	 	 
	Liu Baoquan

	 	 	 	C3267, No.86 Beiyuan Rd, Chaoyang

District Beijing, CHINA, 100101
	 
	 	 	 	 
	Lilja Jaaksi

	 	 	 	Tiilitehtaankatu 23 B 15, FI-65100 VAASA
	 
	 	 	 	 
	Sergey Groshev

	 	 	 	Facul.Of Tech./Dep.Elect.Engin,

P.O.Box 20, FI-53810 LAPPEENRANTA
	 
	 	 	 	 
	Mikko Hämäläinen

	 	 	 	Silakatu 6, FI-53500 LAPPEENRANTA
	 
	 	 	 	 
	Jussi Puranen

	 	 	 	Tervahaudankatu 3 as 7, FI-53850

LAPPEENRANTA
	 
	 	 	 	 
	Kari Koskiniemi

	 	 	 	Nyviksvägen 72, FI-65410 SUNDOM
	 
	 	 	 	 
	Simon Hewitt

	 	 	 	Toinen Linja 23 A 33, FI-00530 HELSINKI
	 
	 	 	 	 
	Mikko Ahonen

	 	 	 	Museonrannantie 4, FI-66400 LAIHIA
	 
	 	 	 	 
	Arita Rajala

	 	 	 	Karjakonkatu 6, FI-65370 VAASA
	 
	 	 	 	 
	Janne Partinen

	 	 	 	Vaihekatu 2 B 23, FI-65320 VAASA
	 
	 	 	 	 
	Mika Koskela

	 	 	 	Tojalantie 111, FI-66400 LAIHIA
	 
	 	 	 	 
	Mona Koskinen

	 	 	 	Katajatie 3, FI-66400 LAIHIA
	 
	 	 	 	 






28









 






	 	 	 	 	 
	Name of Other Stockholder	 	Number of Shares	 	Notice Address
	Jixiang Hao

	 	 	 	Ratavallintie 26 H 59, FI-00720

HELSINKI
	 
	 	 	 	 
	Anssi Lipsanen

	 	 	 	Jousimiehenkatu 10 a as 3, FI-53850

LAPPEENRANTA
	 
	Pekka Hermunen

	 	 	 	Tuohimäentie 100 G, FI-00670 HELSINKI
	 
	 	 	 	 
	Henna Hertsbacka

	 	 	 	Gerbyn Rantatie 3 C 6, FI-65280 VAASA
	 
	 	 	 	 
	Timo Alho

	 	 	 	Aronkyläntie 1 B4, FI-66400 LAIHIA
	 
	 	 	 	 
	Päivi Nykänen

	 	 	 	Höysäläntie 41, 66440 TERVAJOKI
	 
	 	 	 	 
	Marcus Backlund

	 	 	 	Västeråkersvägen 2 B 1, FI-65630

KARPERÖ
	 
	 	 	 	 
	Mika Ikonen

	 	 	 	Koulukatu 66-68 C 32, FI-65100 VAASA
	 
	 	 	 	 
	Ulla-Riitta Nummi

	 	 	 	Nöötöntie 78, FI-65610 MUSTASAARI
	 
	 	 	 	 
	Kari Kankaala

	 	 	 	Vapaudenkatu 20 A 6, FI-40100

JYVÄSKYLÄ
	 
	 	 	 	 
	Jussi Paakkunainen

	 	 	 	Klemetinkatu 11 a 1, FI-65100 VAASA
	 
	 	 	 	 
	Pekka Autio

	 	 	 	Kopelonkatu 1 C 12, FI-65370 VAASA







29











 






EXHIBIT 3


FORM OF PROMISSORY NOTE



AMERICAN SUPERCONDUCTOR CORPORATION (“Purchaser”) will pay to private persons, corporations
and private equity funds listed in Appendix A (“Sellers”) the Principal Amount (as defined below)
on the following terms:





	1	 	Principal Amount
	 
	 	 	The principal amount shall be an amount of EUR [•] equalling to the Shortfall Amount as
defined in the Share Purchase Agreement (the “Agreement”) entered into by and between
Purchaser and Sellers on March 12, 2011, and as amended on June 29, 2011 (the “Principal
Amount”).
	 
	2	 	Interest
	 
	2.1	 	Interest shall accrue on the outstanding Principal Amount at the rate of five
percent (5%) per annum from and including the date of this promissory note until and including
the Maturity Date (as defined below).
	 
	2.2	 	Interest shall be paid on a quarterly basis in arrears on the last business day of
the relevant quarter, with the first interest payment date occurring on [•], 2011, to Sellers’
joint bank account designated by Sellers.
	 
	2.3	 	Purchaser may, in its sole discretion, elect to defer, in whole or in part, any
interest payment (a “Deferred Payment”) on the outstanding Principal Amount. Each amount of
Deferred Payment shall be added to the Principal Amount.
	 
	3	 	Maturity
	 
	 	 	The whole outstanding Principal Amount with any accrued but unpaid interest shall become due
and payable on the first (1st) business day in Finland after the first anniversary of the
date of this promissory note (the “Maturity Date”). On the Maturity Date, Purchaser shall
pay the outstanding Principal Amount and any accrued but unpaid interest thereon to Sellers’
joint bank account designated by Sellers.
	 
	4	 	Prepayment
	 
	 	 	Purchaser may, in its sole discretion, elect to prepay all or a part of the outstanding
Principal Amount together with any accrued but unpaid interest at any time prior to the
Maturity Date without any additional costs.
	 
	5	 	Assignment by Sellers
	 
	 	 	Sellers shall have no right to assign or pledge any rights
under this promissory note.
	 
	6	 	Pari Passu Ranking
	 
	 	 	The Principal Amount and any accrued but unpaid interest thereon shall constitute unsecured
obligations of Purchaser, ranking pari passu with other unsecured obligations of Purchaser.
	 
	7	 	Sellers Representatives
	 
	 	 	Sellers shall be represented by the Sellers’ Representatives (as defined in the Agreement)
in respect of this promissory note.




 









 






	8	 	Governing Law and Dispute Resolution
	 
	8.1	 	This promissory note shall be governed by and construed in accordance with the
substantive laws of Finland.
	 
	8.2	 	Any dispute arising out of or relating to this promissory note shall be finally
settled by arbitration in accordance with the Arbitration Rules of the Stockholm Chamber of
Commerce. The Arbitration Tribunal shall consist of three (3) arbitrators, one (1) to be
appointed by Purchaser, one (1) by Sellers and one (1) arbitrator, serving as the chairman, by
the two arbitrators so appointed. Failing the appointment of an arbitrator or the chairman,
the arbitrator or the chairman, as the case may be, shall be appointed by the Arbitration
Board of the Stockholm Chamber of Commerce. The arbitration shall be held in Stockholm, Sweden
and the arbitral proceedings shall be conducted in the English language, but evidence may be
submitted also in Finnish and/or Swedish and witnesses heard in any of the said languages.





_________________________



In [•] on [•], 2011




AMERICAN SUPERCONDUCTOR CORPORATION



_____________________________



[Name]



[Title]







-2-









 








Appendix A



[insert names of Sellers]





-3-